Clinical Trial Update: A 4-Day Study to Evaluate the Photoxicity of Diacerein 1% Topical Ointment in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing phototoxicity of a 1% diacerein topical ointment in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals

Drugs mentioned

• Diacerein 1% topical ointment (diacerein)

Snippet

Sponsor: Castle Creek Pharmaceuticals, LLC | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2020-02-10